Pathophysiology of migraine: a disorder of sensory processing

Cited by (1,001)

Items 701–800 of 1,001

1. Astrocytic Glutamate Transporters and Migraine
   Fiorenzo Conti, Daniela Pietrobon · 2022 · Neurochemical Research
2. Alterations in post-movement beta event related synchronization throughout the migraine cycle: A controlled, longitudinal study
   Martin Syvertsen Mykland, Marte‐Helene Bjørk, Marit Stjern, Trond Sand · 2017 · Cephalalgia
3. Evidence of Diplopia in Children's Headache Drawings Helps to Differentiate Pseudotumor Cerebri From Migraine
   Erica B. Lee, Fredrick S. Edelman, Carl E. Stafstrom · 2017 · Pediatric Neurology
4. Update on the diagnostic considerations for neurogenic nasal and sinus symptoms: A current review suggests adding a possible diagnosis of migraine
   Frederick A. Godley, Roy R. Casiano, Mark E. Mehle, Brian E. McGeeney, Christopher H. Gottschalk · 2018 · American Journal of Otolaryngology
5. Migraine in women: a review
   Mona Ghadiri–Sani · 2025 · Current Opinion in Neurology
6. Pediatric migraine care: bridging gaps, overcoming barriers, and advancing solutions
   Aynur Özge, Mário Fernando Prieto Peres, Rami Burstein · 2025 · European Journal of Pediatrics
7. Gepants: targeting the CGRP pathway for migraine relief
   Bernadetta Jakubowska, Magdalena Sowa-Kućma · 2025 · Frontiers in Pharmacology
8. Distortion Product Otoacoustic Emissions and Their Suppression as Predictors of Peripheral Auditory Damage in Migraine: A Case-Control Study
   Maria Albanese, Stefano Di Girolamo, Lorenzo Silvani, Eleonora Ciaschi, Barbara Chiaramonte, Matteo Conti, Francesco Maria Passàli, Battista Di Gioia, Nicola Biagio Mercuri, Arianna Di Stadio · 2021 · Journal of Clinical Medicine
9. TRPA1-Mediated Src Family Kinases Activity Facilitates Cortical Spreading Depression Susceptibility and Trigeminovascular System Sensitization
   Lingdi Nie, Liwen Jiang, John Peter Quinn, Blair D. Grubb, Minyan Wang · 2021 · International Journal of Molecular Sciences
10. Focus On Zavegepant: The First Intranasal Third-Generation Gepant
    Damiana Scuteri, Assunta Tarsitano, Paolo Tonin, Giacinto Bagetta, Maria Tiziana Corasaniti · 2022 · Pain Management
11. PACAP-PAC1 receptor inhibition is effective in opioid induced hyperalgesia and medication overuse headache models
    Zachariah Bertels, Elizaveta Mangutov, Kendra Siegersma, Haley C. Cropper, Alycia F Tipton, Amynah A. A. Pradhan · 2023 · iScience
12. Management of Migraine-Associated Vestibulocochlear Disorders
    Kayla K. Umemoto, Karen Tawk, Najva Mazhari, Mehdi Abouzari, Hamid Reza Djalilian · 2023 · Audiology Research
13. Drug-related side effects and adverse reactions in the treatment of migraine: a bibliometric and visual analysis
    Shijie Wei, Hao Lv, Dianhui Yang, Lili Zhang, Xuhao Li, Yike Ning, Yu Tang, Xinyu Wu, Jing Han · 2024 · Frontiers in Neurology
14. Pituitary adenylate cyclase‐activating polypeptide targeted treatments in primary headache disorders
    Nazia Karsan, Lars IH Edvinsson, László Vécsei, Peter James Goadsby · 2024 · Annals of Clinical and Translational Neurology
15. Exploring potential neuroimaging biomarkers for the response to non-steroidal anti-inflammatory drugs in episodic migraine
    Heng‐Le Wei, Yu‐Sheng Yu, Meng-Yao Wang, Gang‐Ping Zhou, Junrong Li, Hong Zhang, Zhengyang Zhou · 2024 · The Journal of Headache and Pain
16. Sumatriptan‐naproxen sodium in migraine: A review
    Robyn‐Jenia Wilcha, Shazia K. Afridi, Piero Barbanti, Hans‐Christoph Diener, Tim Patrick Jürgens, Michel Lantéri‐Minet, Christian Lucas, Jérôme Mawet, Xavier Moisset, Antonio Russo et al. · 2024 · European Journal of Neurology
17. The mysterious link between migraine aura and migraine headache
    Anders Hougaard, Cenk Ayata, K. C. Brennan, Arn M. J. M. van den Maagdenberg, Messoud Ashina · 2025 · PLoS Biology
18. Altered Spontaneous Activity and Functional Connectivity in the Posterior Pons of Patients With Migraine Without Aura
    Zhaoxia Qin, Xinwei He, Jilei Zhang, Shuai Xu, Gefei Li, Jingjing Su, Yan-Hui Shi, Shiyu Ban, Yue Hua Hu, Yi-Sheng Liu et al. · 2019 · Journal of Pain
19. Perceptions, experiences, and understandings of cluster headache among GPs and neurologists: a qualitative study
    Alina Buture, Fayyaz Ahmed, Yachna Mehta, Koen Paemeleire, Peter James Goadsby, Lisa Dikomitis · 2020 · British Journal of General Practice
20. Migraine and Two-Pore-Domain Potassium Channels
    Clément Verkest, Stephanie Häfner, Pablo Ávalos Prado, Anne Baron, Guillaume Sandoz · 2020 · The Neuroscientist
21. Primary headaches during the COVID-19 lockdown in Germany: analysis of data from 2325 patients using an electronic headache diary
    Bianca Raffaelli, Jasper Mecklenburg, Simon Scholler, Lucas Hendrik Overeem, Ana Sofia Oliveira Gonçalves, Uwe Reuter, Lars Neeb · 2021 · The Journal of Headache and Pain
22. The Long and Winding Road—Vestibular Efferent Anatomy in Mice
    Dávid Lőrincz, Lauren A. Poppi, Joseph C. Holt, Hannah R. Drury, Rebecca Lim, Alan M. Brichta · 2022 · Frontiers in Neural Circuits
23. A Comprehensive Review of Zavegepant as Abortive Treatment for Migraine
    Nazir Noor, Alexis L. Angelette, Abby M. Lawson, Anjana Patel, Ivan Urits, Omar Viswanath, Cyrus Yazdi, Alan D. Kaye · 2022 · Health Psychology Research
24. Changes in gamma‐aminobutyric acid and glutamate/glutamine levels in the right thalamus of patients with episodic and chronic migraine: A proton magnetic resonance spectroscopy study
    Xueyan Zhang, Wei Wang, Xiaoyan Bai, Yingkui Zhang, Ziyu Yuan, Hefei Tang, Xue Zhang, Zhiye Li, Peng Zhang, Zhangxuan Hu et al. · 2023 · Headache The Journal of Head and Face Pain
25. Transgender and Migraine
    E. Anne MacGregor, Antoinette MaassenVanDenBrink · 2019 · Headache
26. More Than Meets the Eye: The Eye and Migraine—What You Need to Know
    Kathleen B. Digre · 2018 · Journal of Neuro-Ophthalmology
27. Endogenous Na+, K+-ATPase inhibitors and CSF [Na+] contribute to migraine formation
    Noah B. Gross, Nastaren Abad, David Lichtstein, Shiri Taron, Lorena Aparicio, Alfred Nji Fonteh, Xianghong Arakaki, Robert Paul Cowan, Samuel C. Grant, Michael G. Harrington · 2019 · PLoS ONE
28. Dairy consumption in relation to primary headaches among a large population of university students: The MEPHASOUS study
    Masoume Mansouri, Farshad Sharifi, Mehdi Varmaghani, Hamid Yaghubi, Azad Shokri, Yousef Moghadas Tabrizi, Abbasali Keshtkar, Omid Sadeghi · 2019 · Complementary Therapies in Medicine
29. Migraine: a brain state amenable to therapy
    Michael Eller, Peter James Goadsby · 2019 · The Medical Journal of Australia
30. Vestibular evoked myogenic potential (VEMP) results in migraine and migrainous vertigo
    Doğukan Özdemir, Çetin Kürşad Akpınar, Ömer Küçüköner, Dursun Mehmet Mehel, Ahmet Bedir, Gökhan Akgül, Erkan Can, Abdulkadir Özgür · 2019 · Acta Oto-Laryngologica
31. Signaling Interaction between Facial and Meningeal Inputs of the Trigeminal System Mediates Peripheral Neurostimulation Analgesia in a Rat Model of Migraine
    Shuya Wang, Jia Wang, Kun Liu, Wan-Zhu Bai, Xiang Cui, Shu Han, Xinyan Gao, Bing Zhu · 2020 · Neuroscience
32. Findings in susceptibility weighted imaging in pediatric patients with migraine with aura
    Frauke Kellner‐Weldon, Vera Franziska Lehmann, Philipe S. Breiding, Lorenz Grunder, Raphaela Muri, Manuela Pastore‐Wapp, Sandra Bigi, Roland Wiest, Marwan El‐Koussy, Nedelina Slavova · 2020 · European Journal of Paediatric Neurology
33. Fremanezumab: a disease-specific option for the preventive treatment of migraine, including difficult-to-treat migraine
    Deborah I. Friedman, Joshua M. Cohen · 2020 · Emerging Topics in Life Sciences
34. Lasmiditan for Acute Treatment of Migraine in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Yanbo Yang, Yue Sun, Bixi Gao, Zilan Wang, Zhouqing Chen, Zhong Wang · 2020 · CNS Drugs
35. Approximation to pain‐signaling network in humans by means of migraine
    Jonas A. Hosp, Marco Reisert, Charlotte von Kageneck, Michel Rijntjes, Cornelius Weiller · 2020 · Human Brain Mapping
36. Lasmiditan: an additional therapeutic option for the acute treatment of migraine
    Daniele Martinelli, Vito Bitetto, Cristina Tassorelli · 2021 · Expert Review of Neurotherapeutics
37. Different dosage regimens of Eptinezumab for the treatment of migraine: a meta-analysis from randomized controlled trials
    Zeya Yan, Tao Xue, Shujun Chen, Xin Wu, Xingyu Yang, Guangjie Liu, Shan Gao, Zhouqing Chen, Zhong Wang · 2021 · The Journal of Headache and Pain
38. Epilepsy and migraine: a diagnostic and therapeutic challenge
    Angelo Pascarella, Oreste Marsico, Domenico Abelardo, Roberta Cutellè, Alessandro Bulgari, Cataldo Mummolo, Anna Mammì, Vittoria Cianci, Umberto Aguglia, Edoardo Ferlazzo et al. · 2025 · Frontiers in Pharmacology
39. Migraine and the Gender Divide
    Aimen Vanood, India C. Rangel, Amaal Jilani Starling · 2023 · Neurologic Clinics
40. Transcriptome-wide association study identifies novel candidate susceptibility genes for migraine
    Travis J. Meyers, Jie Yin, Victor A. Herrera, Alice Rogot Pressman, Thomas J. Hoffmann, Catherine A. Schaefer, Andrew L. Avins, Hélène Choquet · 2023 · Human Genetics and Genomics Advances
41. Calcitonin Gene-Related Peptide-Mediated Trigeminal Ganglionitis: The Biomolecular Link between Temporomandibular Disorders and Chronic Headaches
    Linda Sangalli, Brad Eli, Sachi Mehrotra, Suzan Sabagh, James Fricton · 2023 · International Journal of Molecular Sciences
42. Vestibular Migraine Pathophysiology and Treatment: a Narrative Review
    Claire E. J. Ceriani · 2023 · Current Pain and Headache Reports
43. High-definition tDCS over primary motor cortex modulates brain signal variability and functional connectivity in episodic migraine
    Manyoel Lim, Dajung J. Kim, Thiago Dias Nascimento, Alexandre F. M. DaSilva · 2024 · Clinical Neurophysiology
44. Hypothalamic paraventricular stimulation inhibits nociceptive WDR trigeminocervical complex cells via oxytocinergic transmission
    Miguel Condés‐Lara, Guadalupe Martı́nez-Lorenzana, Antonio Espinosa de los Monteros-Zúñiga, Gustavo López-Córdoba, Aketzalli Córdova-Quiroga, Shakty Aracely Flores Bojórquez, Abimael González‐Hernández · 2024 · Journal of Neuroscience
45. Neurological Health in Sexual and Gender Minority Individuals
    Rubinee Simmasalam, Mary C. Zuniga, Holly E. Hinson · 2024 · Seminars in Neurology
46. Update on Cluster Headaches: From Genetic to Novel Therapeutic Approaches
    Myun Kim, Je Kook Yu, Yoo Hwan Kim · 2024 · Headache and Pain Research
47. The TRPA1 Ion Channel Mediates Oxidative Stress-Related Migraine Pathogenesis
    Michał Fila, Łukasz Przysło, Marcin Derwich, Piotr Sobczuk, Elżbieta Pawłowska, Janusz Błasiak · 2024 · Molecules
48. Meningeal brain borders and migraine headache genesis
    Sarah Louise Christensen, Dan Levy · 2024 · Trends in Neurosciences
49. Orofacial Pain
    Meredith J. Barad, Marcela Romero‐Reyes · 2024 · CONTINUUM Lifelong Learning in Neurology
50. Trigeminal cervical complex: A neural network affecting the head and neck
    F Bou Malhab, Jad Hosri, Georges M. Zaytoun, U. Hadi · 2024 · European Annals of Otorhinolaryngology Head and Neck Diseases
51. Potential hypothalamic mechanisms in trigeminal neuropathic pain: a comparative analysis with migraine and cluster headache
    Jaisan Islam, Md Taufiqur Rahman, Muhammad Ali, Elina KC, Young Seok Park · 2024 · The Journal of Headache and Pain
52. Financial Stress Interacts With CLOCK Gene to Affect Migraine
    Dániel Baksa, Xénia Gonda, Nóra Eszlári, Péter Petschner, Veronika Ács, Lajos Kalmár, J.F.W. Deakin, György Bagdy, Gabriella Juhász · 2020 · Frontiers in Behavioral Neuroscience
53. The Influence of Photophobia on Postural Control in Patients With Migraine
    Carina Ferreira Pinheiro, Renato Moraes, Gabriela Ferreira Carvalho, Lais Sestari, Tenysson Will de Lemos, MARCELO EDUARDO BIGAL, Fabíola Dach, Richard E.A. van Emmerik, Débora Bevilaqua‐Grossi · 2020 · Headache The Journal of Head and Face Pain
54. A new approach for examining the neurovascular structure with phalloidin and calcitonin gene-related peptide in the rat cranial dura mater
    Jia Wang, Dongsheng Xu, Jingjing Cui, Shuya Wang, Chen She, Hui Wang, Shuang Wu, Jianliang Zhang, Bing Zhu, Wanzhu Bai · 2020 · Journal of Molecular Histology
55. Open Label Prospective Experience of Supplementation with a Fixed Combination of Magnesium, Vitamin B2, Feverfew, Andrographis Paniculata and Coenzyme Q10 for Episodic Migraine Prophylaxis
    Michail Vikelis, Emmanouil V. Dermitzakis, George S. Vlachos, Panagiotis Soldatos, Konstantinos C. Spingos, Pantelis Litsardopoulos, Evangelia G. Kararizou, Andreas A. Argyriou · 2020 · Journal of Clinical Medicine
56. Lasmiditan for the Treatment of Migraines With or Without Aura in Adults
    Amnon A. Berger, Ariel A. Winnick, Daniel Popovsky, Alicia Kaneb, Kevin Berardino, Adam Marc Kaye, Elyse M. Cornett, Alan D. Kaye, Omar Viswanath, Ivan Urits · 2025 · Psychopharmacology Bulletin
57. Positive airway pressure therapy for chronic pain in patients with obstructive sleep apnea—a systematic review
    Kristian McCarthy, Aparna Saripella, Janannii Selvanathan, Mahesh Nagappa, Marina F Englesakis, David Wang, Philip Peng, Frances F. Chung · 2021 · Sleep And Breathing
58. Optimal Dose of Erenumab for Preventive Treatment of Episodic Migraine: A Systematic Review and Meta-Analysis
    Yanbo Yang, Mingjia Chen, Da Wu, Yue Sun, Fan Jiang, Zhouqing Chen, Zhong Wang · 2021 · Current Neuropharmacology
59. Study on “Atypical” Migraine Auras in the Pediatric Age: The Role of Cortical Spreading Depression and the Physiopathogenetic Hypothesis Arising from Our Clinical Cases
    Vincenzo Raieli, Mariarita Capizzi, Antonio Marino, Giovanni Di Nardo, Umberto Raucci, Pasquale Parisi · 2022 · Life
60. Skin wetness sensitivity across body sites commonly affected by pain in people with migraine
    Alex Buoite Stella, Davide Filingeri, Gabriele Garascia, Laura D’Acunto, Giovanni Furlanis, Antonio Granato, Paolo Manganotti · 2022 · Headache The Journal of Head and Face Pain
61. Cutaneous allodynia and thermal thresholds in chronic migraine: The effect of onabotulinumtoxinA
    Melek Özarslan, Zeliha Matur, Erdem Tüzün, Ali Emre Öge · 2022 · Clinical Neurology and Neurosurgery
62. Characterization of transit rates in the large intestine of mice following treatment with a CGRP antibody, CGRP receptor antibody, and small molecule CGRP receptor antagonists
    Kirk W. Johnson, Xia Li, Xiaofang Huang, Beverly A. Heinz, Jianliang Yu, Baolin Li · 2022 · Headache The Journal of Head and Face Pain
63. Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype
    Karthik Nagaraj, Diana Y. Wei, Francesca Puledda, Hsing‐Yu Weng, Sadaf Waheed, Nicolas Vandenbussche, Jonathan Jia Yuan Ong, Peter James Goadsby · 2022 · Headache The Journal of Head and Face Pain
64. Citalopram Neuroendocrine Challenge Shows Altered Tryptophan and Kynurenine Metabolism in Migraine
    Kinga Gecse, Andrea Edit Édes, Tamás Nagy, Adrienn Katalin Demeter, Dávid Virág, Márton Király, Borbála Dalmadi Kiss, Krisztina Ludányi, Zsuzsanna Környei, Ádám Dénes et al. · 2022 · Cells
65. Altered static functional network connectivity predicts the efficacy of non-steroidal anti-inflammatory drugs in migraineurs without aura
    Heng‐Le Wei, Wenjuan Yang, Gang‐Ping Zhou, Yu‐Chen Chen, Yu‐Sheng Yu, Xindao Yin, Junrong Li, Hong Zhang · 2022 · Frontiers in Molecular Neuroscience
66. Resting-state Quantitative EEG Spectral Patterns in Migraine During Ictal Phase Reveal Deviant Brain Oscillations: Potential Role of Density Spectral Array
    Pooja Ojha, Samhita Panda · 2022 · Clinical EEG and Neuroscience
67. Polymorphisms of the Proinflammatory Cytokine Genes Modulate the Response to NSAIDs but Not to Triptans in Migraine Attacks
    Elisa Rubino, Andrea Marcinnò, Alberto Grassini, Elisa Maria Piella, Fabio Ferrandes, Fausto Roveta, Silvia Boschi, Aurora Cermelli, Salvatore Gallone, Lidia Savi et al. · 2022 · International Journal of Molecular Sciences
68. Cellular and Molecular Roles of Immune Cells in the Gut-Brain Axis in Migraine
    Yichen Zhou, Miaoyi Pang, Yiran Ma, Lingling Lu, Jiannan Zhang, Peipei Wang, Qian Li, Fei Yang · 2023 · Molecular Neurobiology
69. Glutamate receptor antagonists with the potential for migraine treatment
    Anna Ferrari, Cecilia Rustichelli, Carlo Baraldi · 2017 · Expert Opinion on Investigational Drugs
70. Electrophysiological Characteristics of the Migraine Brain: Current Knowledge and Perspectives
    Erica Marucco Fuentes, Marco Lisicki Martinez, Delphine Magis · 2018 · Current Medicinal Chemistry
71. Increased functional connectivity between the right temporo-parietal junction and the temporal poles in migraine without aura
    Marco Lisicki Martinez, Kevin D’Ostilio, Gianluca Coppola, Alain Maertens de Noordhout, Vincenzo Parisi, Jean E. Schoenen, Delphine Magis · 2018 · Cephalalgia Reports
72. Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response
    Jiacheng Lin, Xu Zhang, Chaotong Li, Yingyan Zhang, Hanzhi Lu, Ji-Wei Chen, Zeyu Li, Xuejun Yang, Zhongping Wu · 2020 · Journal of Ethnopharmacology
73. A Markov chain method for counting and modelling migraine attacks
    Mathias Barra, Fredrik Andreas Dahl, Kjersti Grøtta Vetvik, E. Anne MacGregor · 2020 · Scientific Reports
74. An outlook on the trigeminovascular mechanisms of action and side effects concerns of some potential neuropeptidergic antimigraine therapies
    Abimael González‐Hernández, Miguel Condés‐Lara, Enrique García-Boll, Carlos M. Villalón · 2021 · Expert Opinion on Drug Metabolism & Toxicology
75. Allostatic Load in Perimenopausal Women With Migraine
    Pamela Lamisi Alebna, Nasim Maleki · 2021 · Frontiers in Neurology
76. Chronic Migraine
    Catriona Gribbin, Krishna Dani, Alok Tyagi · 2021 · Neurology India
77. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine
    Philipp Burow, Marc Haselier, Steffen Naegel, Leila Motlagh Scholle, Charly Gaul, Torsten Kraya · 2021 · Cells
78. Migraine and Its Equivalents: What Do They Share? A Narrative Review on Common Pathophysiological Patterns
    Ilaria Frattale, Claudia Ruscitto, Laura Papetti, Fabiana Ursitti, Giorgia Sforza, Romina Moavero, Michela Ada Noris Ferilli, Samuela Tarantino, Martina Balestri, Federico Vigevano et al. · 2021 · Life
79. Persistent postural‐perceptual dizziness versus vestibular migraine: A narrative review
    David Moreno‐Ajona · 2025 · Headache The Journal of Head and Face Pain
80. Risk of migraine development among children and adolescents with autism spectrum disorder: A nationwide longitudinal study
    Ting-Yi Lee, Shih‐Jen Tsai, Tzeng‐Ji Chen, Mu‐Hong Chen · 2021 · Research in Autism
81. HCN2 Ion Channels Drive Pain in Rodent Models of Migraine
    Christoforos Tsantoulas, Aidan Ng, Larissa Garcia Pinto, Anna P. Andreou, Peter Anthony McNaughton · 2022 · Journal of Neuroscience
82. Inhibiting neuronal AC1 for treating anxiety and headache in the animal model of migraine
    Ren-Hao Liu, Mingjie Zhang, Man Xue, Tao Wang, Jing-Shan Lu, Xu‐Hui Li, Yuxin Chen, Kexin Fan, Wantong Shi, Si-Bo Zhou et al. · 2023 · iScience
83. Predictors of Response to Fremanezumab in Migraine Patients with at Least Three Previous Preventive Failures: Post Hoc Analysis of a Prospective, Multicenter, Real-World Greek Registry
    Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis · 2023 · Journal of Clinical Medicine
84. Evaluation of Plasma Calcitonin Gene-Related Peptide as a Biomarker for Painful Temporomandibular Disorder and Migraine
    Inna E. Tchivileva, Kirk W. Johnson, Xiyun Chai, Lyndsey R. VanDam, Pei Feng Lim, Gary Douglas Slade · 2023 · Journal of Pain Research
85. Ubrogepant: Mechanism of action, clinical and translational science
    Ramesh Boinpally, Mohamad Shebley, Joel M. Trugman · 2024 · Clinical and Translational Science
86. Reconceptualizing autonomic function testing in migraine: a systematic review and meta-analysis
    Antun R. Pavelić, Karin Zebenholzer, Christian Wöber · 2024 · The Journal of Headache and Pain
87. Molecular Pathways Regulating Circadian Rhythm and Associated Diseases
    Min Ding, Hang Zhou, Yumei Li, Yun‐Wen Zheng · 2024 · Frontiers in Bioscience-Landmark
88. Children and adolescents with primary headaches exhibit altered sensory profiles – a multi-modal investigation
    Michał Pieniak, Berit Höfer, Jenny Knipping, Vanda Faria, Matthias Richter, Valentin Alexander Schriever, Antje Haehner, Gudrun Goßrau · 2024 · The Journal of Headache and Pain
89. Familial hemiplegic migraine
    Maria Dolores Villar‐Martínez, David Moreno‐Ajona, Peter James Goadsby · 2024 · Handbook of clinical neurology
90. Neuromodulation for the treatment of primary headache syndromes
    Jan Hoffmann, Arne May · 2019 · Expert Review of Neurotherapeutics
91. Approach to Pediatric Intractable Migraine
    Mohammed A. Alqahtani, Rebecca Barmherzig, Ana Marissa Lagman‐Bartolome · 2021 · Current Neurology and Neuroscience Reports
92. CGRP and CGRP-Receptor as Targets of Migraine Therapy: Brain Prize-2021
    László Vécsei, János Tajti, Délia Szok, Aliz Nyári · 2021 · CNS & Neurological Disorders - Drug Targets
93. Clinical characteristics and perfusion‐computed tomography alterations in a series of patients with migraine with aura attended as stroke code
    Alicia González‐Martínez, Santiago Trillo, Carmen Benavides‐Bernaldo de Quirós, Laura Casado Fernandez, Antonio Barbosa, Rafael Manzanares López, Ana Beatriz Gago‐Veiga, José Vivancos · 2021 · Headache The Journal of Head and Face Pain
94. Personal view: Modelling pain mechanisms of migraine without aura
    Jes Olesen · 2022 · Cephalalgia
95. Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
    Peter McAllister, Joshua M. Cohen, Verena Ramirez Campos, Xiaoping Ning, Lindsay Janka, Steve Barash · 2022 · The Journal of Headache and Pain
96. Calcitonin gene-related peptide (receptor) antibodies: an exciting avenue for migraine treatment
    Antoinette MaassenVanDenBrink, Gisela Marie Terwindt, Arn M. J. M. van den Maagdenberg · 2018 · Genome Medicine
97. Trigeminal‐Targeted Treatments in Migraine: Is 60% the Magic Number?
    Piero Barbanti, Gabriella Egeo, Dimos Dimitrios Mitsikostas · 2019 · Headache The Journal of Head and Face Pain
98. Investigating the association of receipt of seasonal influenza vaccine with occurrence of anesthesia/paresthesia and severe headaches, Canada 2012/13–2016/17, the Canadian Vaccine Safety Network
    May A Ahmed, Monika Naus, Joel Singer, Louis Valiquette, Brenda L. Coleman, Gaston De Serres, Otto G. Vanderkooi, Karina A. Top, Jennifer E. Isenor, James D. Kellner et al. · 2020 · Vaccine
99. Unmet needs in the acute treatment of migraine attacks and the emerging role of calcitonin gene–related peptide receptor antagonists: An integrative review
    Theresa Mallick‐Searle, Maureen Moriarty · 2020 · Journal of the American Association of Nurse Practitioners
100. Utilization of B12 for the treatment of chronic migraine
     Ivan Urits, Melis Yilmaz, Ehab A. Bahrun, Caitlin Merley, Logan Scoon, Grace Lassiter, Daniel An, Vwaire Orhurhu, Alan D. Kaye, Omar Viswanath · 2020 · Best practice & research. Clinical anaesthesiology